[Action of flupentixol decanoate in chronic psychoses of the schizophrenic type].
D000284:Administration, Oral; D000328:Adult; D002389:Catatonia / Q000188:drug therapy; D002626:Chemistry, Pharmaceutical; D000431:Ethanol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007273:Injections, Intramuscular; D008875:Middle Aged; D010555:Personality Inventory; D010879:Piperazines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011581:Psychological Tests; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy*; D012563:Schizophrenia, Paranoid / Q000188:drug therapy; D013892:Thioxanthenes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors; D014149:Tranquilizing Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D010879:Piperazines; D013892:Thioxanthenes; D014149:Tranquilizing Agents; D000431:Ethanol
Action du decanoate de flupentixol dans les psychoses chroniques de type schizophrénique.